외래 섬유근통 환자의 통증관리를 위한 통합의학 임상경로(Clinical Pathway) 개발 연구
Development of an Integrative Medicine Clinical Pathway for Pain Management in Outpatient Fibromyalgia Patients
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives: This study aimed to develop a Clinical Pathway (CP) for fibromyalgia patients based on integrative medicine. It emphasizes multidisciplinary collaboration to enhance the diagnosis and treatment process while improving pain management and overall quality of life. Methods: The study involved a review of existing fibromyalgia care pathways at the W-institute and an analysis of both domestic and international studies on the condition. Focus Group Interviews (FGI) with experts and Delphi surveys were conducted to evaluate the CP’s validity and feasibility. Based on these findings, a comprehensive CP was created, incorporating processes for diagnosis, treatment, evaluation, and management, along with clinical matrices and algorithms. Results: The literature review and expert feedback underscored the need for standardized diagnostic tools such as the Widespread Pain Index (WPI) and Symptom Severity Scale (SS). Multidisciplinary approaches, including pharmacotherapy, acupuncture, physical therapy, psychotherapy, exercise, and dietary management, were identified as effective treatment options. The Delphi survey revealed high consensus rates regarding the CP’s diagnostic appropriateness (90%), treatment efficacy (95%), and management strategy practicality (93%). Consequently, two CPs were developed—one for Western medicine and another for traditional Korean medicine hospitals—both emphasizing multidisciplinary collaboration. Conclusions: The integrative medicine-based CP for fibromyalgia patients standardizes diagnosis and organizes treatment, thereby enhancing patient quality of life and improving healthcare outcomes. Further research is necessary to assess the long-term effects of the CP and its applicability across various healthcare settings.
Abstract
Objectives: This study aimed to develop a Clinical Pathway (CP) for fibromyalgia patients based on integrative medicine. It emphasizes multidisciplinary collaboration to enhance the diagnosis and treatment process while improving pain management and overall quality of life. Methods: The study involved a review of existing fibromyalgia care pathways at the W-institute and an analysis of both domestic and international studies on the condition. Focus Group Interviews (FGI) with experts and Delphi surveys were conducted to evaluate the CP’s validity and feasibility. Based on these findings, a comprehensive CP was created, incorporating processes for diagnosis, treatment, evaluation, and management, along with clinical matrices and algorithms. Results: The literature review and expert feedback underscored the need for standardized diagnostic tools such as the Widespread Pain Index (WPI) and Symptom Severity Scale (SS). Multidisciplinary approaches, including pharmacotherapy, acupuncture, physical therapy, psychotherapy, exercise, and dietary management, were identified as effective treatment options. The Delphi survey revealed high consensus rates regarding the CP’s diagnostic appropriateness (90%), treatment efficacy (95%), and management strategy practicality (93%). Consequently, two CPs were developed—one for Western medicine and another for traditional Korean medicine hospitals—both emphasizing multidisciplinary collaboration. Conclusions: The integrative medicine-based CP for fibromyalgia patients standardizes diagnosis and organizes treatment, thereby enhancing patient quality of life and improving healthcare outcomes. Further research is necessary to assess the long-term effects of the CP and its applicability across various healthcare settings.
참고문헌 (64)
- Häuser W, "Fibromyalgia", Nat Rev Dis Primers, 1(1), pp.15022~ (2015)[DOI]
- Cheong MJ, "A Case Study Evaluating the Effectiveness of an Interdisciplinary Team-Based Integrated Medical Service Model in Improving the Quality of Life of a Fibromyalgia Patient and Caregiver through Psychological and Various Counseling Interventions", J of Oriental Neuropsychiatry, 35(2), pp.191~203 (2024)[DOI]
- Godfrey RG, "A guide to the understanding and use of tricyclic antidepressants in the overall management of fibromyalgia and other chronic pain syndromes", Arch Intern Med, 156(10), pp.1047~1052 (1996)
- Berwick R, "The diagnosis of fibromyalgia syndrome", Clin Med(Lond), 22(6), pp.570~574 (2022)[DOI]
- Kia S, "Update on Treatment Guideline in Fibromyalgia Syndrome with Focus on Pharmacology", Biomedicines, 5(2), pp.20~ (2017)[DOI]
- Arnold LM, "Challenges of implementing fibromyalgia treatment guidelines in current clinical practice", Postgrad Med, 129(7), pp.709~714 (2017)[DOI]
- Sarzi-Puttini P, "Diagnostic and therapeutic care pathway for fibromyalgia", Clin Exp Rheumatol, 39(Suppl 130(3)), pp.120~127 (2021)[DOI]
- Platz T, "Evidence-Based Guidelines and Clinical Pathways in Stroke Rehabilitation-An International Perspective", Front Neurol, 10, pp.200~ (2019)[DOI]
- Han K, "Application of Health Care Big data and Necessity of Traditional Korean Medicine Data Registry", J Korean Med Obes Res, 17(1), pp.46~53 (2017)[DOI]
- Ko KY, "Developed and Implemented a Clinical Pathway for Lung Cancer Patients Admitted to Korean Medicine Hospital after Standard Treatment", J Physiol & Pathol Korean Med, 37(6), pp.178~184 (2023)[DOI]
- Cho S, "Development of Clinical Pathway Model in Integrative Korean Medicine : Treatment of Noninvasive Breast Cancer", Journal of Society of Preventive Korean Medicine, 26(1), pp.11~23 (2022)[DOI]
- Kwon D, "Developing a Clinical Pathway of Korean Medicine for Managing Patients with Depression", J of Oriental Neuropsychiatry, 34(1), pp.1~12 (2023)[DOI]
- Kim HS, "Management of Diabetes in Coronavirus Disease 2019 : Prognosis and Practical Issues", J Korean Diabetes, 21, pp.120~125 (2020)[DOI]
- Kim M, "Development of a Critical Pathway for a Korean Medicine Hospital Inpatient with Stroke", J Korean Med, 42(2), pp.62~71 (2021)[DOI]
- Lee KJ, "Development of a Standardized Clinical Pathway in Korean Patients with Gastric Cancer Clinical Application Observational Study", J Korean Med, 45(2), pp.74~82 (2024)[DOI]
- Kim EH, "A Longitudinal Path Analysis of Symptom, Fatigue and Quality of life in Patients with Colorectal Cancer during Chemotherapy", J Health Info Stat, 43(3), pp.200~207 (2017)[DOI]
- Han S, "Hip and Finger Degenerative Arthritis Case Series Protocol for Applying Korean Medicine Clinical Pathway", Korean J Acupunct, 41(1), pp.1~6 (2024)[DOI]
- Park H, "Desirable policy direction of support policy for patients with rare and incurable diseases", Korean Journal of Insurance Medicine, 6(1), pp.19~27 (2011)
- Zhang B, "Factors important to patients’ quality of life at the end of life", Arch Intern Med, 172(15), pp.1133~1142 (2012)[DOI]
- Cheong MJ, "Introduction to methodology for the development of an integrative medical service model", Integr Med Res, 11(2), pp.100840~ (2022)[DOI]
- Lee SS, "Diagnosis and Treatment of Fibromyalgia Syndrome", The Korean Journal of Medicine, 84(5), pp.650~658 (2013)[DOI]
- Pfalzgraf AR, "Use of Complementary and Alternative Medicine in Fibromyalgia : Results of an Online Survey", Pain Manag Nurs, 21(6), pp.516~522 (2020)[DOI]
- Munn Z, "Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach", BMC Med Res Methodol, 18(1), pp.143~ (2018)[DOI]
- Kinsman L, "What is a clinical pathway? Development of a definition to inform the debate", BMC Med, 8, pp.31~ (2010)[DOI]
- Lawal AK, "What is a clinical pathway? Refinement of an operational definition to identify clinical pathway studies for a Cochrane systematic review", BMC Med, 14, pp.35~ (2016)[DOI]
- Tetzlaff JM, "Guidelines for randomized clinical trial protocol content : a systematic review", Syst Rev, 1, pp.43~ (2012)[DOI]
- Prokofyeva ES, "Clinical pathways analysis of patients in medical institutions based on hard and fuzzy clustering methods", Business Informatics, 14(1), pp.19~31 (2020)[DOI]
- Gawlik K, "Qualitative methodologies in or ganization studies. Volume II: Methods and possibilities", pp.97~126 (2018), Palgrave Macmillan
- Masser I, "Delphi revisited : Expert opinion in urban analysis", Urban Studies, 24(3), pp.217~225 (1987)[DOI]
- Schwendicke F, "When to intervene in the caries process? An expert Delphi consensus statement", Clin Oral Investig, 23(10), pp.3691~3703 (2019)[DOI]
- Baker J, "How expert are the experts? An exploration of the concept of ‘expert’ within Delphi panel techniques", Nurse Res, 14(1), pp.59~70 (2006)[DOI]
- Katz RS, "Fibromyalgia diagnosis : a comparison of clinical, survey, and American College of Rheumatology criteria", Arthritis Rheum, 54(1), pp.169~176 (2006)[DOI]
- Wolfe F, "New American College of Rheumatology criteria for fibromyalgia : a twenty-year journey", Arthritis Care Res(Hoboken), 62(5), pp.583~584 (2010)[DOI]
- Ahmed S, "Performance of the American College of Rheumatology 2016 criteria for fibromyalgia in a referral care setting", Rheumatol Int, 39(8), pp.1397~1403 (2019)[DOI]
- Miotto K, "Trends in Tramadol : Pharmacology, Metabolism, and Misuse", Anesth Analg, 124(1), pp.44~51 (2017)[DOI]
- White PF, "The role of non-opioid analgesic techniques in the management of pain after ambulatory surgery", Anesth Analg, 94(3), pp.577~585 (2002)[DOI]
- Ko Y, "The pharmacological management of neuropathic pain", J Korean Med Assoc, 55(6), pp.582~592 (2012)[DOI]
- Lian YN, "Duloxetine for pain in fibromyalgia in adults : a systematic review and a metaanalysis", Int J Neurosci, 130(1), pp.71~82 (2020)[DOI]
- Tzellos TG, "Gabapentin and pregabalin in the treatment of fibromyalgia : a systematic review and a meta-analysis", J Clin Pharm Ther, 35(6), pp.639~656 (2010)[DOI]
- Crofford LJ, "Pregabalin for the treatment of fibromyalgia syndrome : results of a randomized, double-blind, placebo-controlled trial", Arthritis Rheum, 52(4), pp.1264~1273 (2005)[DOI]
- Tofferi JK, "Treatment of fibromyalgia with cyclobenzaprine : A meta-analysis", Arthritis Rheum, 51(1), pp.9~13 (2004)[DOI]
- Affaitati G, "A randomized, controlled study comparing a lidocaine patch, a placebo patch, and anesthetic injection for treatment of trigger points in patients with myofascial pain syndrome : evaluation of pain and somatic pain thresholds", Clin Ther, 31(4), pp.705~720 (2009)[DOI]
- Russell IJ, "Treatment of primary fibrositis", fibromyalgia syndrome with ibuprofen and alprazolam. A double-blind, placebo-controlled study, 1991, pp.34(5), 552~560
- Goldenberg DL, "A randomized, controlled trial of amitriptyline and naproxen in the treatment of patients with fibromyalgia", Arthritis Rheum, 29(11), pp.1371~1377 (1986)[DOI]
- Yeo M, "A National Survey on Utilization of Pattern Identification among Korean Medicine Doctors", Journal of Society of Preventive Korean Medicine, 19(3), pp.45~55 (2015)[DOI]
- Song N, "A Study for the objective diagnosis by statistical analysis to the Bian Zheng questionnaire", Korean Journal of Oriental Meidicne, 11(1), pp.127~138 (2005)
- Häuser W, "Review of pharmacological therapies in fibromyalgia syndrome", Arthritis Res Ther, 16(1), pp.201~ (2014)[DOI]
- Calandre EP, "An update on pharmacotherapy for the treatment of fibromyalgia", Expert Opin Pharmacother, 16(9), pp.1347~1368 (2015)[DOI]
- Choi ES, "Update in Fibromyalgia", Clinical Pain, 9(2), pp.72~76 (2010)
- Han SS, "The Effect of a Tai-Chi Self-helf Program for Fibromyalgia Patient", J Muscle Joint Health, 14(2), pp.169~180 (2007)
- Kim SH, "Psychiatric Approach of Fibromyalgia", Journal of Rheumatic Diseases, 18(4), pp.242~252 (2011)[DOI]
- Kong KR, "Effects of a Cognitive Behavior Therapy Program for Patients with Fibromyalgia Syndrome : A Randomized Controlled Trial", J Korean Acad Nurs, 51(3), pp.347~362 (2021)[DOI]
- Offenbächer M, "Physical therapy in the treatment of fibromyalgia", Scand J Rheumatol Suppl, 113, pp.78~85 (2000)[DOI]
- Lee JY, "The Clinical Study on a Case of Fibromyalgia Syndrome Patient by Korean Medicine Treatment", Journal of Korean Medicine, 26(4), pp.127~136 (2016)[DOI]
- Lim KS, "Yoga Self-help Management Program for the Patients with Fibromyalgia syndrome Effect on Health status and Depression", Journal of Digital Convergence, 16(3), pp.457~468 (2018)[DOI]
- da Silva GD, "Effects of yoga and the addition of Tui Na in patients with fibromyalgia", J Altern Complement Med, 13(10), pp.1107~1113 (2007)[DOI]
- Kim SM, "The Effects of Physical activities, Social activities and Subjective Psychological Symptoms of Therapeutic Massage on Fibromyalgia Syndrome", Journal of Coaching Development, 9(2), pp.269~280 (2007)
- Kim MC, "The literature review of fibromyalgia syndrome", Journal of Korean Physical Therapy, 16(4), pp.23~37 (2004)
- Lee Y, "Fibromyalgia from the Psychiatric Perspective", Korean J Psychosom Med, 28(2), pp.99~107 (2020)[DOI]
- Kim MC, "One Case Report of Fibromyalgia Syndrome(FMS)Patient Improved by Korean Medical Combined Treatment", The Korean Medicine Society for the Herbal Formula Study, 20(1), pp.149~158 (2012)[DOI]
- Kim ES, "Fibromyalgia Syndrome Combined with Insomnia and Depression Disorder Managed with Korean Medical Treatment : A Case Report", J Int Korean Med, 36(3), pp.400~409 (2015)
- Choi MK, "The Recognition and Attitude of Users Using the Combined Western-Oriental Medical Institutions", Journal of the Korean Society of Health Informaion and Health Statistics, 30(1), pp.35~44 (2005)
- Arnold LM, "AAPT Diagnostic Criteria for Fibromyalgia", J Pain, 20(6), pp.611~628 (2019)[DOI]
- Häuser W, "European* clinical practice recommendations on opioids for chronic noncancer pain-Part 1 : Role of opioids in the management of chronic noncancer pain", Eur J Pain, 25(5), pp.949~968 (2021)[DOI]
